Eisai Mergers & Acquisitions

Eisai M&A Summary

Eisai has acquired 2 companies, including 1 in the last 5 years. It has also divested 2 assets.

Eisai’s largest acquisition to date was in 2010, when it acquired AkaRx for $255M. It’s largest disclosed sale occurred in 2019, when it sold Eisai - Two Medicines to ADVANZ PHARMA for $33M. Eisai has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity2
    • M&A Sell Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 2

Eisai, Inc.

100 Tice Boulevard,
Woodcliff Lake, New Jersey 07677
United States,
(201) 692-1100
www.us.eisai.com

All (4) Buy (2) Sell (2)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2024-03-06 C2N Diagnostics · Life Science
St. Louis, Missouri · www.c2n.com

C2N provides clinical laboratory services and advanced diagnostic solutions in the field of brain health. The company's high-resolution mass spectrometry-based biomarker services and products are used for clinical decision-making to improve patient care, including diagnosis and treatment monitoring; maximizing the quality and efficiency of clinical trials that test novel treatments for neurodegeneration; and providing innovative tools to help healthcare researchers better understand novel mechanisms of disease, identify new treatment targets, and conduct important epidemiologic studies to improve global public health. C2N is based in St. Louis, Missouri.

- Growth Capital

Eisai, Inc.

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.